Fibromyalgia in lupus erythematosus

Acta Dermato-Venereologica

Volumn 79, Issue 1, 1999, Pages 62-64

  Gräfe, Andrea ^b   Wollina, Uwe ^a   Tebbe, Beate ^b   Sprott, Haiko ^b   Uhlemann, Christine ^b   Hein, Gert ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b NONE

Author keywords

Fibromyalgia; Lupus erythematosus

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID;

ADULT; AGED; ALOPECIA; ARTHRALGIA; ARTICLE; CLINICAL EXAMINATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FIBROMYALGIA; FOLLOW UP; HEADACHE; HUMAN; HYPERGAMMAGLOBULINEMIA; MAJOR CLINICAL STUDY; MORNING STIFFNESS; MYALGIA; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGAMMAGLOBULINEMIA; AGE FACTORS; AGE OF ONSET; AGED; ANTIBODIES, ANTICARDIOLIPIN; BLOOD CELL COUNT; DRUG THERAPY; FEMALE; FIBROMYALGIA; FOLLOW-UP STUDIES; GERMANY; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, DISCOID; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; RHEUMATOID FACTOR; SEX FACTORS;

EID: 0002216357     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/000155599750011732     Document Type: Article

References (15)

1. 1. Lund-Olesen LH, Lund-Olesen K. The etiology and possible treatment of chronic fatigue syndrome/fibromyalgia. Med Hypotheses 1994; 43: 55-58.
2. 2. Vaeroy H, Sakurada T, Forre O, et al. Modulation of pain in fibromyalgia (fibrositis syndrome): cerebrospinal fluid (CSF) investigation of pain related neuropeptides with special reference to calcitonin gene related peptide (CGRP). J Rheumatol Suppl 1989; 19: 94-97.
3. 3. Berg PA, Klein R. Fibromyalgie-Syndrom. Eine neuroendokrinologische Autoimmunerkrankung. Dtsch Med Wochenschr 1994; 119: 429-435.
4. 4. Sprott H, Hein G, Domke D, et al. Enthesiopathien Diagnostik und Therapie. Z Ärztl Fortbild 1996; 90: 711-718.
5. 5. Middleton GD, McFarlin JE, Lipsky PE. The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 1994; 37: 1181-1188.
6. 6. Morand EF, Miller MH, Whittingham S, Littlejohn GO. Fibromyalgia syndrome and disease activity in systemic lupus erythematosus. Lupus 1994; 3: 187-191.
7. 7. Pistiner M, Wallace DJ, Nessim S, et al. Lupus erythematosus in the 1980s; a survey of 570 patients. Semin Arthritis Rheum 1991; 21: 55-64.
8. 8. Romano TJ. Coexistence of fibromyalgia syndrome and systemic lupus erythematosus. Scand J Rheumatol (Suppl) 1992; 94: 12.
9. 9. Hein G, Wollina U, Uhlemann C. Management of dermato-rheumatologic syndromes. Br J Rheumatol 1998; 37: 463.
10. 10. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
11. 11. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990; 33: 160-179.
12. 12. Vitali C, Bencivelli W, Isenberg DA, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology. II. Identification of the variables indicative of disease activity and their use in development of an activity score. Clin Exp Rheumatol 1992; 10: 541-547.
13. 13. Benchivelli W, Vitali C, Isenberg DA, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology. III. Development of a computerized clinical chart and its application to the comparison of different indices of disease activity. Clin Exp Rheumatol 1992; 10: 549-554.
14. 14. Tebbe B, Mansmann U, Wollina U, et al. Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients. Acta Derm Venereol (Stockh) 1997; 77: 305-308.
15. 15. Littlejohn GO, Granges G. The relationship between vertebral dysfunction and clinical features of fibromyalgia syndrome. J Orthopaed Rheumatol 1995; 8: 97-105.